Based on PubMed | Is it true that metoprolol can be used in chickens, and if so, what is the appropriate dosage and what cautions should be considered?

Metoprolol use in chickens: what is known, what isn’t, and how to proceed safely

There is no established, approved metoprolol dose for chickens in clinical veterinary practice, and its use would be considered extra‑label with significant uncertainty. Available evidence in birds comes mainly from research models and from studies with other beta‑blockers, not from standardized dosing guidelines for poultry. Because of this, any use in chickens should be guided by a veterinarian with avian expertise, with careful monitoring for bradycardia (slow heart rate), hypotension (low blood pressure), and respiratory effects. ^[1]

What the research shows

• Beta‑blockers clearly affect cardiovascular function in domestic fowl. In conscious roosters, beta‑blockers such as propranolol and atenolol lowered arterial pressure and heart rate, but cardioselectivity seen in mammals did not clearly translate to birds. This suggests birds may respond differently to beta‑blockers and that “cardioselective” beta‑1 agents might still have broader effects in avian species. ^[1]
• Metoprolol has been evaluated in chick embryo models. Metoprolol exposure reduced heart rate and, at certain stages, decreased cardiac output; high doses were linked to embryo death, indicating dose‑dependent cardiovascular depression. These embryo data underscore the risk of bradycardia and reduced cardiac output with metoprolol in avian systems, especially with higher doses. ^[2]
• Experimental embryo studies also show interactions with other cardiac drugs (for example, verapamil plus metoprolol) can increase the risk of structural heart problems, highlighting the need for caution with drug combinations. In practice, combining metoprolol with other rate‑slowing or calcium‑channel–blocking agents could heighten risk in birds. ^[3]

Is there an appropriate dose?

There are no widely accepted, peer‑reviewed clinical dosing guidelines for metoprolol in chickens. Unlike dogs or cats where metoprolol has published guidance, chickens lack validated dose ranges, pharmacokinetics, and safety margins for metoprolol. ^[1]

• In mammals, metoprolol is subject to first‑pass hepatic metabolism and has variable plasma levels, which complicates predictable dosing; translating this to birds is risky without species‑specific data. Given birds’ different physiology and drug metabolism, extrapolating mammalian doses may lead to under‑ or overdosing. ^[4]
• Other beta‑blockers have been studied in birds, but even these showed limited cardioselectivity and variable effects, reinforcing that metoprolol’s “beta‑1 selectivity” may not ensure a predictable safety profile in chickens. Until avian pharmacokinetic and safety data exist for metoprolol, selecting a precise dose is not evidence‑based. ^[1]

Practical cautions if considering extra‑label use

If a veterinarian determines that a beta‑blocker is necessary and metoprolol is considered, a cautious, individualized approach is prudent.

• Baseline assessment

  • Obtain heart rate, rhythm (ECG if available), blood pressure if feasible, and respiratory status before dosing. Birds can decompensate quickly with excessive beta blockade, so a baseline is essential. ^[1]

• Start low, go slow (under veterinary supervision)

  • Because embryo studies show marked heart rate reduction and decreased cardiac output with higher doses of metoprolol, conservative titration with close monitoring is advisable. Watch for bradycardia, lethargy, weakness, collapse, cool extremities, or labored breathing as signs of excessive effect. ^[2]

• Avoid risky combinations

  • Be very cautious with other negative chronotropes or AV‑node–blocking drugs (e.g., diltiazem/verapamil, digoxin), as embryo research suggests combined effects can heighten cardiovascular risk. Polypharmacy may compound bradycardia or conduction block in birds. ^[3]

• Respiratory considerations

  • Although metoprolol is beta‑1 selective, cardioselectivity may be incomplete in birds; beta‑blockers can worsen bronchoconstriction in mammals with airway disease and may pose respiratory risks in birds as well. Monitor for any respiratory compromise, particularly in birds with airway issues. ^[1]

• Reproductive caution

  • Given embryo data showing dose‑related bradycardia and mortality, avoid use in breeding birds, during egg formation, or incubation when possible. Drug exposure during embryonic development can adversely affect chick viability. ^[2]

• Monitoring plan

  • Reassess heart rate and clinical status after the first dose and with dose changes; if available, repeat ECG and blood pressure checks. Discontinue or reduce dose at the first signs of clinically important bradycardia or hypotension. ^[1]

Alternatives to consider

Because metoprolol lacks avian dosing standards, some clinicians may consider beta‑blockers with more published avian experience (e.g., propranolol or atenolol in research settings), though even these lack robust, standardized clinical protocols in poultry. Choice of agent should be based on the specific cardiovascular problem, the bird’s condition, and the veterinarian’s experience, recognizing that all beta‑blocker use in chickens remains extra‑label and evidence‑limited. ^[1]

---

Key takeaways

• There is no established “appropriate dosage” of metoprolol for chickens in clinical practice; its use is extra‑label and not supported by standardized avian dosing references. ^[1]
• Research in chick embryos shows metoprolol can markedly slow heart rate and reduce cardiac output at higher doses, raising safety concerns, especially in developing chicks. ^[2]
• If considered at all, metoprolol should be used only under veterinary supervision with low starting doses, careful monitoring, and avoidance of interacting drugs. ^{[3] [1]}

Table: Evidence snapshot for beta‑blocker use in domestic fowl

• Evidence type:

  • Embryo studies (metoprolol): Reduced HR and cardiac output; dose‑related embryo mortality. ^[2]
  • Adult research (other beta‑blockers): Decreased blood pressure and HR; limited cardioselectivity in birds. ^[1]

• Clinical guidance availability:

  • Metoprolol dosing standard in chickens: Not available. ^[1]
  • Pharmacokinetic certainty in birds: Lacking; mammalian PK indicates high first‑pass metabolism and variability that may not translate. ^[4]

• Practical risk flags:

  • Bradycardia, hypotension, respiratory effects, drug interactions, reproductive/embryo toxicity. ^{[2] [3] [1]}

If you’re managing a specific condition in a chicken (for example, supraventricular tachycardia or hypertension), working with an avian veterinarian to define goals, monitoring, and a stepwise plan is the safest path given the current evidence base.